Quantcast

Latest Medical research Stories

2014-07-07 12:28:59

Engineered Cells Known As CTL019 Are the First Therapy of Their Kind to Obtain Designation PHILADELPHIA, July 7, 2014 /PRNewswire/ -- A University of Pennsylvania-developed personalized immunotherapy has been awarded the U.S. Food and Drug Administration's Breakthrough Therapy designation for the treatment of relapsed and refractory adult and pediatric acute lymphoblastic leukemia (ALL). The investigational therapy, known as CTL019, is the first personalized cellular therapy for the...

2014-07-02 23:11:19

InSilico Medicine, Inc. announces today: after decades of theoretical research and animal experimentation, the industry, academia and the policy makers will discuss the possible avenues for translating the leading laboratory discoveries into clinical practice. Baltimore, MD (PRWEB) July 02, 2014 Alex Zhavoronkov, PhD, CEO of InSilico Medicine, Inc. and Bhupinder Bhullar, PhD, the laboratory director of the Novartis Institute for Biomedical Research (NIBR) are co-organizing the...

2014-06-26 16:24:59

BOULDER, Colo., IRVINE, Calif. and LIEGE, Belgium, June 26, 2014 /PRNewswire/ -- BiOptix, in conjunction with Altermune Technologies announced today the presentation of a poster for "Quantitative SPR Screening of Aptamer-Protein Interactions for Pre-Clinical Development" at the Drug Analysis 2014 meeting in Liege, Belgium. The meeting combines the 10(th) International Symposium of Drug Analysis and the 25(th) Annual International Symposium on Pharmaceutical and Biomedical Analysis...

2014-06-24 12:27:39

PHILADELPHIA, June 24, 2014 /PRNewswire-USNewswire/ -- The Pew Charitable Trusts and the Alexander and Margaret Stewart Trust announced the inaugural class of Pew-Stewart Scholars for Cancer Research. Five promising early-career scientists will receive funding for research aimed at finding cures for cancer using approaches that include genetics, pharmacology, and structural biology. "Cancer continues to take a terrible toll on human health worldwide, and creative approaches are vital...

2014-06-23 08:27:50

Phase 1 Clinical Data Highlights Factor IXa as an Excellent Target for Anticoagulation Therapy BASKING RIDGE, N.J., June 23, 2014 /PRNewswire/ -- Regado Biosciences, Inc. (Nasdaq: RGDO), a biopharmaceutical company focused on the discovery and development of actively controllable aptamer therapeutics for the acute care setting, today announced the publication in the Journal of Thrombosis and Thrombolysis of data from a single escalating-dose Phase 1 clinical trial of the REG2...

2014-06-20 23:05:52

Scott Hammond, MD, Executive Director of University of California, Santa Barbara's Translational Medicine Research Lab (TMRL), has developed “The New Medicine” article series. Articles will appear monthly on the medical professional news and information website Medical-Horizons.net. Emerson, NJ (PRWEB) June 20, 2014 Medical-Horizons.net, an online news and information resource for healthcare professionals covering the latest advances from the nation’s top medical facilities, has...

2014-06-19 23:10:34

Transparency Market Research added a new report "Imaging Biomarkers Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019" to its report store. Browse the full report: http://www.transparencymarketresearch.com/imaging-biomarkers-market.html. Albany, New York (PRWEB) June 19, 2014 Biomarkers also known as biological markers are characteristics that are measured in order to assess and predict biological condition of the body and thus help...

2014-06-19 08:28:26

RICHMOND, Calif., June 19, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced the appointment of H. Stewart Parker to the Company's Board of Directors. Ms. Parker, who founded and served as President and CEO of Targeted Genetics Corporation, brings more than 30 years of experience in the biotechnology industry, including 16 years of specific experience in cell and gene therapy. http://photos.prnewswire.com/prnvar/20130102/SF35903LOGO "We are very pleased to...

2014-06-18 23:10:57

OMICS Group International is pleased to announce the 3rd International Conference and Exhibition on Cell & Gene Therapy to be held during October 27-29, 2014 in Las Vegas, USA. Cell Therapy conference takes the opportunity to explore the cell and magnify the therapeutization potential on the application grounds of genetic knowhow. Henderson, NV (PRWEB) June 18, 2014 Cell Therapy-2014 is a remarkable event which brings together research eminent from the expertise of cell and gene...

2014-06-18 04:21:16

Unique Immuno-Oncolytic Therapy Gets Closer to a More Effective, Safer Cancer Treatment and Potential Cure CLEVELAND, June 18, 2014 /PRNewswire-USNewswire/ --­­ Western Oncolytics Ltd., a biotech company specializing in immuno-oncolytic cancer therapies, has closed $275,000 in seed funding. The proceeds are planned to set a path toward clinical trials and execute initial manufacturing for its novel virus-based cancer therapy, which delivers genes to guide the immune system to kill...


Latest Medical research Reference Libraries

Bulletin of the World Health Organization
2012-06-04 20:04:03

The Bulletin of the World Health Organization is a public health journal established in 1947 and published monthly by the World Health Organization (WHO). The editor-in-chief is Adetokunbo O. Lucas. The journal aims to offer publish health policy and practice guidance based on the best evidence available, while encouraging closer links between scientific investigation and the art of helping populations to lead healthier lives. Articles are published in English and abstracts are available...

British Journal of Cancer
2012-05-28 10:11:32

The British Journal of Cancer (BJC) is a professional medical journal published biweekly by the Nature Publishing Group (a division of Macmillan Publishers Ltd.) on behalf of Cancer Research UK. It provides a forum for clinicians and scientists to communicate original research findings that have relevance to understanding the etiology of cancer and to improving patient treatment and survival. Papers are published both in print and online. The journal publishes full research papers and...

Disease Models & Mechanisms
2012-05-12 21:51:28

Disease Models & Mechanisms (DMM) is a peer-reviewed open-access biomedical journal published by The Company of Biologists, a UK non-profit publisher of international biological journals, such as Journal of Cell Science and the journal Development. The journal covers the mechanisms, diagnostics and treatment of human disease. The journal publishes original research and review articles, and aims to promote communication between basic researchers, translational researchers and...

Antiviral Chemistry & Chemotherapy
2012-04-25 09:59:26

Antiviral Chemistry & Chemotherapy is a peer-reviewed academic journal published bi-monthly by International Medical Press in London since 1997. When founded in January 1990, it was published by Blackwell Science. The current editor-in-chief is Hugh J. Field of University of Cambridge, UK. The journal publishes primary papers and reviews on all aspects of the preclinical development of antiviral agents, including their chemical synthesis, biochemistry, pharmacology, mode of action and...

More Articles (4 articles) »
Word of the Day
callithump
  • A somewhat riotous parade, accompanied with the blowing of tin horns, and other discordant noises; also, a burlesque serenade; a charivari.
'Callithump' is a back-formation of 'callithumpian,' a 'fanciful formation' according to the Oxford English Dictionary. However, the English Dialect Dictionary, says 'Gallithumpians' is a Dorset and Devon word from the 1790s that refers to 'a society of radical social reformers' or 'noisy disturbers of elections and meetings.'
Related